Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review
- PMID: 31194018
- PMCID: PMC6545445
- DOI: 10.1016/j.gendis.2019.04.001
Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review
Abstract
The emergence of antibiotic resistant bacteria in the healthcare is a serious concern. In the Healthcare premises precisely intensive care unit are major sources of microbial diversity. Recent findings have demonstrated not only microbial diversity but also drug resistant microbes largely habitat in ICU. Pseudomonas aeruginosa found as a part of normal intestinal flora and a significant pathogen responsible for wide range of ICU acquired infection in critically ill patients. Nosocomial infection associated with this organism including gastrointestinal infection, urinary tract infections and blood stream infection. Infection caused by this organism are difficult to treat because of the presence of its innate resistance to many antibiotics (β-lactam and penem group of antibiotics), and its ability to acquire further resistance mechanism to multiple class of antibiotics, including Beta-lactams, aminoglycosides and fluoroquinolones. In the molecular evolution microbes adopted several mechanism to maintain genomic plasticity. The tool microbe use for its survival is mainly biofilm formation, quorum sensing, and horizontal gene transfer and enzyme promiscuity. Such genomic plasticity provide an ideal habitat to grow and survive in hearse environment mainly antibiotics pressure. This review focus on infection caused by Pseudomonas aeruginosa, its mechanisms of resistance and available treatment options. The present study provides a systemic review on major source of Pseudomonas aeruginosa in ICU. Further, study also emphasizes virulence gene/s associated with Pseudomonas aeruginosa genome for extended drug resistance. Study gives detailed overview of antibiotic drug resistance mechanism.
Keywords: Antibiotics; Blood stream infections; Infection; Pathogen; Resistance; Urinary tract infections.
Figures
Similar articles
-
Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.APMIS Suppl. 2003;(116):1-47. APMIS Suppl. 2003. PMID: 14692154 Review.
-
Genomic Characterization of Imipenem- and Imipenem-Relebactam-Resistant Clinical Isolates of Pseudomonas aeruginosa.mSphere. 2021 Dec 22;6(6):e0083621. doi: 10.1128/mSphere.00836-21. Epub 2021 Nov 24. mSphere. 2021. PMID: 34817240 Free PMC article.
-
Overview of mechanisms of antibiotic resistance in Pseudomonas aeruginosa: an ocular perspective.Clin Exp Optom. 2018 Mar;101(2):162-171. doi: 10.1111/cxo.12621. Epub 2017 Oct 18. Clin Exp Optom. 2018. PMID: 29044738 Review.
-
Antibiotic Resistance in Pseudomonas.Adv Exp Med Biol. 2022;1386:117-143. doi: 10.1007/978-3-031-08491-1_5. Adv Exp Med Biol. 2022. PMID: 36258071
-
Characteristics of Microbial Factors of Healthcare-Associated Infections Including Multidrug-Resistant Pathogens and Antibiotic Consumption at the University Intensive Care Unit in Poland in the Years 2011-2018.Int J Environ Res Public Health. 2020 Sep 23;17(19):6943. doi: 10.3390/ijerph17196943. Int J Environ Res Public Health. 2020. PMID: 32977435 Free PMC article.
Cited by
-
Current Treatment Strategies Against Multidrug-Resistant Bacteria: A Review.Curr Microbiol. 2022 Nov 3;79(12):388. doi: 10.1007/s00284-022-03061-7. Curr Microbiol. 2022. PMID: 36329256 Free PMC article. Review.
-
Analysis of the Distribution and Antibiotic Resistance of Pathogens Causing Infections in Hospitals from 2017 to 2019.Evid Based Complement Alternat Med. 2022 Sep 16;2022:3512582. doi: 10.1155/2022/3512582. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 36159558 Free PMC article.
-
Carbapenem Combinations for Infections Caused by Carbapenemase-Producing Pseudomonas aeruginosa: Experimental In Vitro and In Vivo Analysis.Antibiotics (Basel). 2022 Sep 7;11(9):1212. doi: 10.3390/antibiotics11091212. Antibiotics (Basel). 2022. PMID: 36139991 Free PMC article.
-
Occurrence of plasmid-mediated quinolone resistance genes in Pseudomonas aeruginosa strains isolated from clinical specimens in southwest Iran: a multicentral study.Sci Rep. 2022 Feb 10;12(1):2296. doi: 10.1038/s41598-022-06128-4. Sci Rep. 2022. PMID: 35145139 Free PMC article.
-
Growing emergence of drug-resistant Pseudomonas aeruginosa and attenuation of its virulence using quorum sensing inhibitors: A critical review.Iran J Basic Med Sci. 2021 Jun;24(6):699-719. doi: 10.22038/IJBMS.2021.49151.11254. Iran J Basic Med Sci. 2021. PMID: 34630947 Free PMC article. Review.
References
-
- Boucher H.W., George H., Talbot J. Bad bugs, No drugs: No ESKAPE! An update from the infectious diseases society of America. Clin Infect Dis. 2009;48(1):1–12. - PubMed
-
- Carlet J., Ben A.A., Tabah A. Multidrug resistant infections in the ICU: mechanisms, prevention and treatment. In: Kuhlen R., Moreno R., Ranieri V.M., Rhodes A., editors. 25 Years of Progress and Innovation in Intensive Care Medicine. Medizinisch Wissenschaftliche Verlagsgesellschaft; Berlin, Germany: 2007. pp. 199–211.
-
- Esposito S., Leone S. Antimicrobial treatment for intensive care unit (ICU) infections including the role of the infectious disease specialist. Int J Antimicrob Agents. 2007;29:494–500. - PubMed
-
- Moore L.S., Freeman R., Gilchrist M. Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108,717 clinical isolates from primary, secondary and tertiary care patients in London. J Antimicrob Chemother. 2014;69(12):3409–3422. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources